Agomab Therapeutics Receives Positive Rating: Five New Stock Coverage Ratings on Tuesday

Wall Street's top analysts changed their outlooks on these popular stocks. To view the full list of all analyst rating changes, including upgrades, downgrades, and new coverage, please see our analyst ratings page.

Goldman Sachs analyst Leah Jordan initiated coverage on Jersey Mike's Subs with a Neutral rating and a price target of $26. Jersey Mike's Subs closed Monday at $23.53. See what other analysts are saying about the stock.

Piper Sandler analyst Yasmeen Rahimi initiated coverage on Agomab Therapeutics NV with an Overweight rating and a price target of $60. Agomab Therapeutics stock closed Monday at $12.82. See what other analysts are saying about the stock.

BofA Securities analyst Jason Gerberry initiated coverage on Apnimed Inc with a Buy rating and a price target of $41. Apnimed closed Monday at $25.63. See what other analysts are saying about the stock.

KeyBanc analyst Jeffrey Hammond initiated coverage on JBT Marel Corp with an Overweight rating and a price target of $150. JBT Marel stock closed Monday at $115.08. See what other analysts are saying about the stock.

Oppenheimer analyst Colin Rusch initiated coverage on Kodiak AI Inc with an Outperform rating and a price target of $9. Kodiak AI closed Monday at $3.79. See what other analysts are saying about the stock.

Considering buying AGMB stock? Here's what analysts are saying.